April 7 and 28 Wine and Spirits Tasting: Avant Garde Tour de France
Wine & Spirits Tastings take place every first and fourth Thursday
, with the first spirit served at 5:30 p.m. Wine & Spirits Tastings include a flight of four wines and hors doeuvres for $20 per person.
Upcoming Wine & Spirits Tastings:
- April 7 & 28 Avant Garde Tour de France
- May 5 & 26 Napa Valley Classics
- June 2 & 23 Michigan Magic
Mick & Macks Chefs Tables take place every third Thursday
, with the first course served at 5:30 p.m. The three-course meal is paired with three distinct wines or spirits for $20 per person.
Upcoming Chefs Tables:
- April 21 Secrets of the Middle East
- May 19 The Age of Bourbon
- June 16 Cheese Please!
Other beverage selections available. Must be 21 or older and present valid ID to buy and consume alcohol. To reserve your table for upcoming
Think Thursdays
! events, call 513-556-3135 or email
.
View the full 2015-2016 schedule online.
And think about reserving Mick & Macks for your next event!
Mick & Mack's logo
Mick & Macks Contemporary Café
Tangeman University Center, Level 3
uc.edu/mick_macks
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.